Article Versions Notes

Blot M, Léopold V, de Beer R, Florquin S, Butler JM, van’t Veer C, de Vos AF, van der Poll T. The Sirt1 Activator SRT1720 Mitigates Human Monocyte Activation and Improves Outcome During Gram-Negative Pneumosepsis in Mice. International Journal of Molecular Sciences. 2025; 26(19):9309. https://doi.org/10.3390/ijms26199309

Blot, Mathieu, Valentine Léopold, Regina de Beer, Sandrine Florquin, Joe M. Butler, Cornelis van’t Veer, Alex F. de Vos, and Tom van der Poll. 2025. "The Sirt1 Activator SRT1720 Mitigates Human Monocyte Activation and Improves Outcome During Gram-Negative Pneumosepsis in Mice" International Journal of Molecular Sciences 26, no. 19: 9309. https://doi.org/10.3390/ijms26199309

Blot, M., Léopold, V., de Beer, R., Florquin, S., Butler, J. M., van’t Veer, C., de Vos, A. F., & van der Poll, T. (2025). The Sirt1 Activator SRT1720 Mitigates Human Monocyte Activation and Improves Outcome During Gram-Negative Pneumosepsis in Mice. International Journal of Molecular Sciences, 26(19), 9309. https://doi.org/10.3390/ijms26199309